Alan Holmer

Insider Reports History

Entity
Individual
Location
C/O Corbus Pharmaceuticals Holdings, Inc, 100 River Ridge Drive, Norwood, MA
Signature
/s/ Meghan Houghton, attorney-in-fact for Alan Holmer
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Alan Holmer:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Corbus Pharmaceuticals Holdings, Inc. Director Common Stock, par value $0.0001 per share 5.83K $175K $30.00 Jun 14, 2024 Direct
Corbus Pharmaceuticals Holdings, Inc. Director Common Stock 1.38K $6.85K $4.97 Jan 26, 2024 Direct
Corbus Pharmaceuticals Holdings, Inc. Director Options to purchase common stock 0 $0 $4.97 Jun 14, 2024 Direct

Insider Reports Filed by Alan Holmer

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CRBP Corbus Pharmaceuticals Holdings, Inc. Jun 14, 2024 2 $50K 4 Jun 14, 2024 Director
CRBP Corbus Pharmaceuticals Holdings, Inc. May 30, 2024 1 $0 4 Jun 3, 2024 Director
CRBP Corbus Pharmaceuticals Holdings, Inc. May 16, 2024 1 $0 4 May 20, 2024 Director
CRBP Corbus Pharmaceuticals Holdings, Inc. Jan 26, 2024 2 $0 4 Jan 30, 2024 Director
CRBP Corbus Pharmaceuticals Holdings, Inc. May 18, 2023 1 $0 4 May 22, 2023 Director
CRBP Corbus Pharmaceuticals Holdings, Inc. May 18, 2022 1 $0 4 May 19, 2022 Director
CRBP Corbus Pharmaceuticals Holdings, Inc. Jun 17, 2021 2 $0 4 Jun 17, 2021 Director